The hidden value of early patient centricity: practical solutions for early phase trials

Patient centricity is often overlooked in the early phases of drug development, even though it has been shown to significantly improve the outcomes of clinical trials for patients, investigators, and sponsors. Luckily, there are creative ways to approach patient centricity that make it not only feasible, but advantageous for early phase trials.

In this article, learn about five economical and efficient ways to make early phase trials both patient-centric and more effective.

Previous Video
Parexel Biotech – designed with biotech’s unique way of working in mind
Parexel Biotech – designed with biotech’s unique way of working in mind

James Anthony, SVP, Global Head Biotech and Graciela Rácaro, SVP, Global Head, Biotech Operations, both fro...

Next Flipbook
Plan & engage early to manage the risks of risk management
Plan & engage early to manage the risks of risk management